Regulation of testicular function in men: implications for male hormonal contraceptive development.
Level 5 - mechanism / opinion, no new human data
Narrative review describing endocrine physiology and male contraceptive principles without original data or systematic review methods.
PubMed 12943722 · doi:10.1016/s0960-0760(03)00205-x
What was done
This narrative review summarizes the neuroendocrine regulation of the hypothalamic-pituitary-testicular axis in adult men, focusing on the feedback mechanisms of testosterone, estradiol, dihydrotestosterone, and inhibin B on gonadotropin secretion, and examines how these pathways inform the design of reversible male hormonal contraceptives.
What was found
The abstract provides no numerical data. It reports that exogenous testosterone alone suppresses pituitary gonadotropins and spermatogenesis in most, but not all, men. Combining testosterone with a second agent—such as a progestin or a GnRH antagonist—produces more complete gonadotropin suppression and inhibits spermatogenesis in almost all men.
Why it matters
Understanding the feedback control of male reproductive endocrinology underpins the rationale for combination hormonal regimens aimed at developing reliable, reversible male contraceptives.
Limits
The abstract describes a narrative overview rather than original empirical research or a systematic review. No quantitative effect sizes, participant numbers, dosing regimens, safety outcomes, or post-treatment reversibility rates are reported.
Cited by
- supports Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis by inhibiting GnRH release from the hypothalamus and gonadotropins (LH and FSH) from the pituitary.